Epidemiological and clinical characteristics	Risk factors	Prevalence of thrombophilia in the study population
Age: 37 years [IQR : 31 – 45] Sexe: Male: 32 (42.7%); Female: 43 (57.3%) Number of episodes: 01 episode: 65 (86.7%) More than 02 episodes: 10 (13.3%) Cryptogenic: 60 (80%) History of DVT or ischemic stroke: 09 (12%) History of foetal loss: 05 (6.7%)	Contraception 20 (26.7%) Smoking 19 (25.3%) High blood pressure 17 (22.7%) Dyslipidemia 10 (13.3%) Diabetes 10 (13.3%) Obesity 09 (12%)	Inherited thrombophilia: 08 (12%) Protein C deficiency: 01 (1.30%) Protein S deficiency: 05 (6.80%) Activated protein C resistance: 02 (2.70%) Antiphospholipid syndrome: 06 (08%) Lupus anticoagulant: 04 (05.30%) Anti‐β2GPI: 02 (2.70%) Anticardiolipin: 03 (04%)